21/09 Olof Stranding appointed Interim CEO of ScandiDos AQ
17/09 Affarsvarlden issues a neutral recommendation for Scandidos FW
17/09 ScandiDos AB Reports Earnings Results for the First Quarter Ended July 31, 2026 CI
25/06 Interview with Anders Murman, CEO of Scandidos FW
17/06 ScandiDos AB Reports Earnings Results for the Fourth Quarter and Full Year Ended April 30, 2026 CI
15/05 ScandiDos Unveils Delta4 SRS Pro at ESTRO 2026: Setting a New Standard for Stereotactic QA AQ
15/05 ScandiDos AB Unveils Delta4 SRS Pro at ESTRO 2026 CI
06/05 Anders Murman appointed Acting CEO of ScandiDos AQ
06/05 ScandiDos AB Announces CEO Changes CI
18/03 Scandidos Q3 net sales SEK 13.7 mln RE
18/03 ScandiDos AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2026 CI
16/12 ScandiDos AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2025 CI
18/25/18 ScandiDos AB Reports Earnings Results for the First Quarter Ended July 31, 2025 CI
18/25/18 Scandidos Q1 net sales SEK 11.5 million RE
18/25/18 ScandiDos AB Reports Earnings Results for the Full Year Ended April 30, 2025 CI
18/25/18 Scandidos Q4 EBITDA At SEK -0.2 Mln RE
12/25/12 Scandidos Q3 Net Sales SEK 17.7 Mln RE
12/25/12 ScandiDos AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2025 CI
17/24/17 ScandiDos AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2024 CI
21/24/21 ScandiDos Names Madrid Hospital as Reference Center in Spain MT
21/24/21 ScandiDos Expands with New Reference Center in Madrid, Spain AQ
18/24/18 ScandiDos AB Reports Earnings Results for the First Quarter Ended July 31, 2024 CI
18/24/18 ScandiDos AB Reports Earnings Results for the Fourth Quarter Ended April 30, 2024 CI
18/24/18 Successful user meeting in Madrid highlights ScandiDos' innovative solutions AQ
11/24/11 ScandiDos - HemmaHos FW
No results match your criteria